Industry Insight
Information, Observation & Analysis
Vaccination against these four specific diseases is recommended prior to travel to endemic areas.
Childhood vaccines are widely recognized as safe, but a growing minority of parents are choosing not have their children immunized.
Recent U.S. Food and Drug Administration advisory committee strain recommendations could make this season’s influenza (flu) vaccine more effective than ever. But, will an epidemic of public apathy undermine immunization efforts?
The efficacy of influenza (flu) vaccines has been greatly improved over the past several decades, but the flu virus still severely sickens hundreds of thousands of individuals each year. Is it possible that scientists have discovered a way to change that?
Hard-to-treat bacterial skin infections are becoming more common. A better understanding of them is the first step toward improving treatment.
Polio still plagues a few parts of the world, and some of its past victims are vulnerable to a recurrence but in a less serious form.
The plasma donor is the first vital part of the process to produce safe and effective plasma protein therapeutics, and the industry prioritizes the safety and health of its plasma donors.
Although venomous snakebites are rare in the U.S. compared to other countries, they are still medical emergencies that need to be treated with today’s safe and effective methods.
A physician diagnoses the condition and either treats it or refers the patient to someone else for treatment. End of story. Or is that just the beginning of the story? Narrative medicine challenges the medical model by bringing a new tool to the table: the story of the patient.
Screening and new treatments offer a high cure rate for those affected by hepatitis C, which was once a grave disease.
Although noncommunicable diseases are the leading cause of morbidity and mortality in most developed nations, zoonotic diseases remain a major public health concern.
As it has since the first commercially produced factor VIII concentrate transformed the lives of U.S. hemophilia A patients, innovation is still the life-blood of this industry.